John Carl Clements, MD | |
106 Alexander Bank Dr Ste 200, Mooresville, NC 28117-9624 | |
(704) 660-2622 | |
(704) 660-2633 |
Full Name | John Carl Clements |
---|---|
Gender | Male |
Speciality | Gastroenterology |
Experience | 32 Years |
Location | 106 Alexander Bank Dr Ste 200, Mooresville, North Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1881612364 | NPI | - | NPPES |
891050T | Medicaid | NC | |
2238519A | Other | PTAN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0100X | Internal Medicine - Gastroenterology | 9700509 (North Carolina) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Lake Norman Regional Medical Center | Mooresville, NC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mooresville Ppm Llc | 3577614791 | 38 |
News Archive
Clinicians and researchers from Montefiore Medical Center and the Albert Einstein College of Medicine of Yeshiva University will present new findings from eight abstracts at the International Federation of Head and Neck Oncologic Societies World Congress being held July 26 - July 30 in New York.
MicroDose Therapeutx, Inc. today announced that the first human subject has been dosed in a Phase 1 clinical trial of MDT-637, MicroDose's inhalable small molecule antiviral fusion inhibitor for the treatment of respiratory syncytial virus.
A genetic test developed at UPMC proved highly sensitive at determining which pancreatic cysts are most likely to be associated with one of the most aggressive types of pancreatic cancer, UPMC and University of Pittsburgh School of Medicine scientists reported in Gut, the journal of the British Society of Gastroenterology.
In the first-ever study combing the entire human genome for genetic determinants of male sexual orientation, a University of Illinois at Chicago researcher has identified several areas that appear to influence whether a man is heterosexual or gay.
› Verified 2 days ago
Entity Name | Mooresville Ppm Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1700028982 PECOS PAC ID: 3577614791 Enrollment ID: O20090630000206 |
News Archive
Clinicians and researchers from Montefiore Medical Center and the Albert Einstein College of Medicine of Yeshiva University will present new findings from eight abstracts at the International Federation of Head and Neck Oncologic Societies World Congress being held July 26 - July 30 in New York.
MicroDose Therapeutx, Inc. today announced that the first human subject has been dosed in a Phase 1 clinical trial of MDT-637, MicroDose's inhalable small molecule antiviral fusion inhibitor for the treatment of respiratory syncytial virus.
A genetic test developed at UPMC proved highly sensitive at determining which pancreatic cysts are most likely to be associated with one of the most aggressive types of pancreatic cancer, UPMC and University of Pittsburgh School of Medicine scientists reported in Gut, the journal of the British Society of Gastroenterology.
In the first-ever study combing the entire human genome for genetic determinants of male sexual orientation, a University of Illinois at Chicago researcher has identified several areas that appear to influence whether a man is heterosexual or gay.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
John Carl Clements, MD 106 Alexander Bank Dr Ste 200, Mooresville, NC 28117-9624 Ph: (704) 660-2622 | John Carl Clements, MD 106 Alexander Bank Dr Ste 200, Mooresville, NC 28117-9624 Ph: (704) 660-2622 |
News Archive
Clinicians and researchers from Montefiore Medical Center and the Albert Einstein College of Medicine of Yeshiva University will present new findings from eight abstracts at the International Federation of Head and Neck Oncologic Societies World Congress being held July 26 - July 30 in New York.
MicroDose Therapeutx, Inc. today announced that the first human subject has been dosed in a Phase 1 clinical trial of MDT-637, MicroDose's inhalable small molecule antiviral fusion inhibitor for the treatment of respiratory syncytial virus.
A genetic test developed at UPMC proved highly sensitive at determining which pancreatic cysts are most likely to be associated with one of the most aggressive types of pancreatic cancer, UPMC and University of Pittsburgh School of Medicine scientists reported in Gut, the journal of the British Society of Gastroenterology.
In the first-ever study combing the entire human genome for genetic determinants of male sexual orientation, a University of Illinois at Chicago researcher has identified several areas that appear to influence whether a man is heterosexual or gay.
› Verified 2 days ago
Aileen Deng, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 170 Medical Park Rd Ste 101, Mooresville, NC 28117 Phone: 980-302-7070 Fax: 980-302-7075 | |
Laila Noor Menon, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 170 Medical Park Rd, Mooresville, NC 28117 Phone: 704-664-9506 | |
Patrick L. Fry, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 170 Medical Park Rd, Ste 140a, Mooresville, NC 28117 Phone: 704-663-4443 | |
Dr. Suraj Arora, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 134 Medical Park Rd Ste 200, Mooresville, NC 28117 Phone: 704-384-7972 Fax: 704-384-7973 | |
Richard Krumdieck, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 170 Medical Park Road, Ste 101, Mooresville, NC 28117 Phone: 704-799-3946 Fax: 704-799-3956 | |
Dr. Stephen Peter Stowe, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 603 East Center St, Suite A, Mooresville, NC 28115 Phone: 704-663-5090 Fax: 704-663-5502 | |
Dr. Smitha Reddy Pasula, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 930 W Wilson Ave, Mooresville, NC 28117 Phone: 704-663-7500 |